Academic Journal

Resolved hyperthyroidism before IVF is not associated with improved cumulative live birth rates: a retrospective cohort study.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Resolved hyperthyroidism before IVF is not associated with improved cumulative live birth rates: a retrospective cohort study.
Συγγραφείς: Jin H; Department of Obstetrics and Gynecology, Center for Reproductive Medicine; Guangdong Provincial Key Laboratory of Major Obstetrics Disease; Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology; Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine; The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China., Luo J; Department of Obstetrics and Gynecology, Center for Reproductive Medicine; Guangdong Provincial Key Laboratory of Major Obstetrics Disease; Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology; Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine; The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China., Wu M; Department of Obstetrics and Gynecology, Center for Reproductive Medicine; Guangdong Provincial Key Laboratory of Major Obstetrics Disease; Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology; Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine; The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China., Fang Y; Department of Biomedical Engineering, City University of Hong Kong, Hong Kong, Hong Kong SAR, China., Xu Z; Department of Obstetrics and Gynecology, Center for Reproductive Medicine; Guangdong Provincial Key Laboratory of Major Obstetrics Disease; Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology; Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine; The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China., Zhu L; Department of Obstetrics and Gynecology, Center for Reproductive Medicine; Guangdong Provincial Key Laboratory of Major Obstetrics Disease; Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology; Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine; The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China., Cao M; Department of Obstetrics and Gynecology, Center for Reproductive Medicine; Guangdong Provincial Key Laboratory of Major Obstetrics Disease; Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology; Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine; The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China., Liang Z; Department of Obstetrics and Gynecology, Center for Reproductive Medicine; Guangdong Provincial Key Laboratory of Major Obstetrics Disease; Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology; Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine; The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China., Wang J; Department of Obstetrics and Gynecology, Center for Reproductive Medicine; Guangdong Provincial Key Laboratory of Major Obstetrics Disease; Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology; Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine; The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China., Lin Y; Department of Obstetrics and Gynecology, Center for Reproductive Medicine; Guangdong Provincial Key Laboratory of Major Obstetrics Disease; Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology; Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine; The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China., Wu Y; Department of Obstetrics and Gynecology, Center for Reproductive Medicine; Guangdong Provincial Key Laboratory of Major Obstetrics Disease; Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology; Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine; The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China., Peng W; Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.; Department of Gynecologic Oncology, Anhui Provincial Cancer Hospital, Hefei, China., Liu H; Department of Obstetrics and Gynecology, Center for Reproductive Medicine; Guangdong Provincial Key Laboratory of Major Obstetrics Disease; Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology; Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine; The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China., Liu JQ; Department of Obstetrics and Gynecology, Center for Reproductive Medicine; Guangdong Provincial Key Laboratory of Major Obstetrics Disease; Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology; Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine; The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Πηγή: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2026 Jun 02; Vol. 17, pp. 1749355. Date of Electronic Publication: 2026 Jun 02 (Print Publication: 2026).
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE
Imprint Name(s): Original Publication: [Lausanne : Frontiers Research Foundation]
Ιατρικοί όροι (MeSH): Hyperthyroidism*/complications , Hyperthyroidism*/therapy , Fertilization in Vitro*/methods , Live Birth*/epidemiology , Infertility, Female*/therapy , Birth Rate*, Humans ; Female ; Retrospective Studies ; Pregnancy ; Adult ; Pregnancy Rate ; Follow-Up Studies ; Oocyte Retrieval
Περίληψη: Background: Hyperthyroidism adversely impacts female reproduction, yet its association with in vitro fertilization (IVF) outcomes remains controversial. It remains unknown whether ovarian function recovers upon achieving euthyroidism. We compared the IVF outcomes among women with active hyperthyroidism (AH), resolved hyperthyroidism (RH), and normal control (NC) patients.
Methods: This retrospective study included patients undergoing their first oocyte retrieval cycle from January 2014 to September 2022, the follow-up lasted for two years. Thyroid function (TSH, FT3, FT4) was classified using the most recent test performed within 3 months before oocyte retrieval. Patients were categorized into three groups: AH, RH, and NC group based on the thyroid hormone level and disease history. The primary outcome was cumulative live birth rate (CLBR) per aspiration cycle. Multivariable logistic regression and inverse probability weighting (IPW) were used to evaluate the association, with adjustment for baseline characteristics and treatment protocols. Subgroup analysis examined the association between hyperthyroidism duration and CLBRs in patients in the AH/RH groups.
Results: 17,621 patients were involved, with 257 in the AH group, 297 in the RH group, and 17,067 in the NC group. The fresh cycle LBR was significantly lower in group AH compared to NC (31.9% vs. 43.7%, P = 0.034). CLBRs were 42.3% in group AH, 44.1% in RH, and 54.9% in NC. Adjusted models revealed lower LBR and CLBR in group AH versus NC, and no significant differences between group AH and RH. In the subgroup of patients with hyperthyroidism, longer duration of hyperthyroidism was negatively associated with cumulative live birth (aOR=0.9990 (0.9985-0.9995), P< 0.001).
Conclusions: Preconception hyperthyroidism was associated with poorer IVF outcomes, and longer disease duration was associated with a lower CLBR.
(Copyright © 2026 Jin, Luo, Wu, Fang, Xu, Zhu, Cao, Liang, Wang, Lin, Wu, Peng, Liu and Liu.)
Competing Interests: The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Contributed Indexing: Keywords: cumulative live birth rate; fertility; hyperthyroidism; in vitro fertilization; live birth rate; resolved hyperthyroidism
Entry Date(s): Date Created: 20260619 Date Completed: 20260619 Latest Revision: 20260619
Update Code: 20260619
PubMed Central ID: PMC13273757
DOI: 10.3389/fendo.2026.1749355
PMID: 42318210
Βάση Δεδομένων: MEDLINE